Artemisia dracunculus L. polyphenols complexed to soy protein show enhanced bioavailability and hypoglycemic activity in C57BL/6 mice

Nutrition

Volumn 30, Issue 7-8 SUPPL., 2014, Pages S4-

  Ribnicky, David M ^a   Roopchand, Diana E ^a   Poulev, Alexander ^a   Kuhn, Peter ^a   Oren, Andrew ^a   Cefalu, William T ^b   Raskin, Ilya ^a  

^a RUTGERS UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Artemisia dracunculus; Bioaccessibility; Bioavailability; Chalcones; Metabolic syndrome; PMI 5011; Polyphenols; Russian tarragon; TIM 1; Type 2 diabetes

Indexed keywords

2', 4' DIHYDROXY 4 METHOXYDIHYDROCHALCONE; ALCOHOL; ANTIDIABETIC AGENT; ARTEMISIA DRACUNCULUS EXTRACT; ARTEMISIA DRACUNCULUS EXTRACT PLUS GELUCIRE; ARTEMISIA DRACUNCULUS EXTRACT PLUS NUTRASORB; GELUCIRE; GLUCOSE; METFORMIN; PLANT EXTRACT; POLYPHENOL; SOYBEAN PROTEIN; UNCLASSIFIED DRUG; 2',4'-DIHYDROXY-4-METHOXYDIHYDROCHALCONE; CHALCONE DERIVATIVE; PMI-5011;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; COMPLEX FORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG GLUCURONIDATION; DRUG POTENTIATION; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; ANIMAL; ARTEMISIA; BIOAVAILABILITY; BLOOD; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; DIABETES MELLITUS, EXPERIMENTAL; INTESTINE ABSORPTION; MOUSE; PHYTOTHERAPY;

ANIMALS; ARTEMISIA; BIOLOGICAL AVAILABILITY; CHALCONES; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; SOYBEAN PROTEINS;

EID: 84905905554     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.03.009     Document Type: Article

References (34)

1. Cefalu W.T., Ye J., Zuberi A., Ribnicky D.M., Raskin I., Liu Z., et al. Botanicals and the metabolic syndrome. Am J Clin Nutr 2008, 87:481S-487S.
2. Graf B.L., Raskin I., Cefalu W.T., Ribnicky D.M. Plant-derived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs 2010, 11:1107-1115.
3. Visioli F., De La Lastra C.A., Andres-Lacueva C., Aviram M., Calhau C., Cassano A., et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 2011, 51:524-546.
4. Obolskiy D., Pischel I., Feistel B., Glotov N., Heinrich M. Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. J Agric Food Chem 2011, 59:11367-11384.
5. Wang Z.Q., Ribnicky D., Zhang X.H., Zuberi A., Raskin I., Yu Y., et al. An extract ofArtemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice. J Nutr Biochem 2011, 22:71-78.
6. Wang Z.Q., Ribnicky D., Zhang X.H., Raskin I., Yu U., Cefalu W.T. Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metabolism 2008, 57(Suppl 1):S58-S64.
7. Ribnicky D.M., Poulev A., Watford M., Cefalu W.T., Raskin I. Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 2006, 13:550-557.
8. Schmidt B., Ribnicky D.M., Poulev A., Logendra S., Cefalu W.T., Raskin I. A natural history of botanical therapeutics. Metabolism 2008, 57(Suppl 1):S3-S9.
9. Logendra S., Ribnicky D.M., Yang H., Poulev A., Ma J., Kennelly E.J., et al. Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 2006, 67:1539-1546.
10. Govorko D., Logendra S., Wang Y., Esposito D., Komarnytsky S., Ribnicky D.M., et al. Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. Am J Physiol Endocrinol Metab 2007, 293:E1503-E1510.
11. Landete J.M. Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr 2012, 52:936-948.
12. Humberstone A.J., Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997, 25:103-128.
13. Ribnicky D.M., Poulev A., Schmidt B., Cefalu W.T., Raskin I. Evaluation of botanicals for improving human health. Am J Clin Nutr 2008, 87:472S-475S.
14. Koga K., Kawashima S., Murakami M. Invitro and in situ evidence for the contribution of Labrasol (R) and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine. Eur J Pharm Biopharm 2002, 54:311-318.
15. Svensson A., Neves C., Cabane B. Hydration of an amphiphilic excipient, Gelucire (R) 44/14. Int J Pharm 2004, 281:107-118.
16. Shen Y., Lu Y., Jv M., Hu J., Li Q., Tu J. Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats. Drug Dev Ind Pharm 2011, 37:1415-1421.
17. Yuksel N., Karatas A., Ozkan Y., Savaser A., Ozkan S.A., Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: invitro and invivo evaluation. Eur J Pharm Biopharm 2003, 56:453-459.
18. Ribnicky D.M., Kuhn P., Poulev A., Logendra S., Zuberi A., Cefalu W.T., et al. Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L. Int J Pharm 2009, 370:87-92.
19. Bandyopadhyay P., Ghosh A.K., Ghosh C. Recent developments on polyphenol-protein interactions: effects on tea and coffee taste, antioxidant properties and the digestive system. Food Funct 2012, 3:592-605.
20. Roopchand D.E., Grace M.H., Kuhn P., Cheng D.M., Plundrich N., Poulev A., et al. Efficient sorption of polyphenols to soybean flour enables natural fortification of foods. Food Chem 2012, 131:1193-1200.
21. Roopchand D.E., Kuhn P., Poulev A., Oren A., Lila M.A., Fridlender B., et al. Biochemical analysis and invivo hypoglycemic activity of a grape polyphenol-soybean flour complex. J Agric Food Chem 2012, 60:8860-8865.
22. Roopchand D.E., Kuhn P., Rojo L.E., Lila M.A., Raskin I. Blueberry polyphenol-enriched soybean flour reduces hyperglycemia, body weight gain and serum cholesterol in mice. Pharmacol Res 2013, 68:59-67.
23. Cheng D.M., Kuhn P., Rojo L.E., Lila M.A., Raskin I. Invivo and invitro antidiabetic effects of aqueous cinnamon extract and cinnamon polyphenol-enhanced food matrix. Food Chem 2012, 135:2994-3002.
24. Grace M.H., Guzman I., Roopchand D.E., Moskal K., Cheng D.M., Pogrebnyak N., et al. Stable binding of alternative protein-enriched food matrices with concentrated cranberry bioflavonoids for functional food applications. J Agric Food Chem 2013, 61:6856-6864.
25. Plundrich N., Grace M.H., Raskin I., Ann Lila M. Bioactive polyphenols from muscadine grape and blackcurrant stably concentrated onto protein-rich matrices for topical applications. Int J Cosmet Sci 2013, 35:394-401.
26. Roopchand D.E., Krueger C.G., Moskal K., Fridlender B., Lila M.A. Food-compatible method for the efficient extraction and stabilization of cranberry pomace polyphenols. Food Chem 2013, 141:3664-3669.
27. Nieman D.C., Gillitt N.D., Knab A.M., Shanely R.A., Pappan K.L., Jin F., et al. Influence of a polyphenol-enriched protein powder on exercise-induced inflammation and oxidative stress in athletes: a randomized trial using a metabolomics approach. PLoS One 2013, 8:e72215.
28. Minekus M., Smeets-Peeters M., Bernalier A., Marol-Bonnin S., Havenaar R., Marteau P., et al. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 1999, 53:108-114.
29. Ribnicky D.M., Roopchand D.E., Oren A., Grace M., Poulev A., Lila M.A., et al. Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1). Food Chem 2014, 142:349-357.
30. Ribnicky D.M., Poulev A., O'Neal J., Wnorowski G., Malek D.E., Jäger R., et al. Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods. Food Chem Toxicol 2004, 42:585-598.
31. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(Suppl):230S-242S.
32. Raskin I., Ripoll C. Can an apple a day keep the doctor away?. Curr Pharm Des 2004, 10:3419-3429.
33. Grace M.H., Ribnicky D.M., Kuhn P., Poulev A., Logendra S., Yousef G.G., et al. Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton. Phytomedicine 2009, 16:406-415.
34. Stachulski A.V., Meng X. Glucuronides from metabolites to medicines: a survey of the invivo generation, chemical synthesis and properties of glucuronides. Nat Prod Rep 2013, 30:806-848.